Biofrontera AG: Forecast Increase

Leverkusen (pta003/14.02.2026/13:15 UTC+1)

Biofrontera AG is raising its forecast for the fiscal year 2025. Based on preliminary figures, EBITDA is expected to be between EUR 3.5 million and EUR 5 million (previous expectation: EUR 1.5 million to EUR 3.5 million). The previous revenue forecast of EUR 17 million to EUR 20 million remains unchanged.

(end)

Emitter:	Biofrontera AG Hemmelrather Weg 201 51377 Leverkusen Germany
Contact Person:	Investor Relations
Phone:	+49 (0) 214 87 63 20
E-Mail:	ir@biofrontera.com
Website:	www.biofrontera.com
ISIN(s):	DE000A4BGGM7 (Share)
Stock Exchange(s):	Regulated Market in Dusseldorf, Frankfurt; Free Market in Munich, Stuttgart, Tradegate BSX